[go: up one dir, main page]

BRPI0806538A2 - Derivados de glicinamida de espiropiperidina - Google Patents

Derivados de glicinamida de espiropiperidina

Info

Publication number
BRPI0806538A2
BRPI0806538A2 BRPI0806538-1A2A BRPI0806538A BRPI0806538A2 BR PI0806538 A2 BRPI0806538 A2 BR PI0806538A2 BR PI0806538 A BRPI0806538 A BR PI0806538A BR PI0806538 A2 BRPI0806538 A2 BR PI0806538A2
Authority
BR
Brazil
Prior art keywords
spyropiperidine
glycinamide derivatives
glycinamide
derivatives
spyropiperidine glycinamide
Prior art date
Application number
BRPI0806538-1A2A
Other languages
English (en)
Inventor
Caterina Bissantz
Erwin Goetschi
Christophe Grundschober
Raffaello Masciadri
Hasane Ratni
Mark Rogers-Evans
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0806538A2 publication Critical patent/BRPI0806538A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0806538-1A2A 2007-01-12 2008-01-03 Derivados de glicinamida de espiropiperidina BRPI0806538A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07100486 2007-01-12
PCT/EP2008/050028 WO2008084005A1 (en) 2007-01-12 2008-01-03 Spiropiperidine glycinamide derivatives

Publications (1)

Publication Number Publication Date
BRPI0806538A2 true BRPI0806538A2 (pt) 2014-04-22

Family

ID=39201768

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0806538-1A2A BRPI0806538A2 (pt) 2007-01-12 2008-01-03 Derivados de glicinamida de espiropiperidina

Country Status (17)

Country Link
US (3) US20080171760A1 (pt)
EP (1) EP2104677B1 (pt)
JP (1) JP2010515700A (pt)
KR (1) KR101129791B1 (pt)
CN (1) CN101583615B (pt)
AR (1) AR064831A1 (pt)
AT (1) ATE536356T1 (pt)
AU (1) AU2008204491B2 (pt)
BR (1) BRPI0806538A2 (pt)
CA (1) CA2674958A1 (pt)
CL (1) CL2008000059A1 (pt)
ES (1) ES2376378T3 (pt)
IL (1) IL199583A0 (pt)
MX (1) MX2009007411A (pt)
PE (1) PE20081851A1 (pt)
TW (1) TW200836728A (pt)
WO (1) WO2008084005A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2009119394A (ru) * 2006-12-07 2011-01-20 Ф. Хоффманн-Ля Рош Аг (Ch) Производные спиро-пиперидина в качестве антагонистов рецептора v1a
CA2673307A1 (en) * 2006-12-22 2008-07-03 F. Hoffman-La Roche Ag Spiro-piperidine derivatives
EP2104677B1 (en) * 2007-01-12 2011-12-07 F. Hoffmann-La Roche AG Spiropiperidine glycinamide derivatives
WO2010054961A1 (en) 2008-11-13 2010-05-20 F. Hoffmann-La Roche Ag Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
EP2358714B1 (en) 2008-11-18 2012-08-01 F. Hoffmann-La Roche AG Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
MY150837A (en) 2008-11-28 2014-02-28 Hoffmann La Roche Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
US8420633B2 (en) 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
PL3083633T3 (pl) 2013-12-19 2018-04-30 F.Hoffmann-La Roche Ag Spirooksazolony
TW201600522A (zh) 2014-02-20 2016-01-01 赫孚孟拉羅股份公司 螺-唑酮
AU2015345102A1 (en) * 2014-11-14 2017-03-30 F. Hoffmann-La Roche Ag Spiro-thiazolones

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3370091A (en) 1964-06-15 1968-02-20 Hoffmann La Roche 2 aminobenzhydrylhalides
US3531467A (en) 1966-12-23 1970-09-29 Hoffmann La Roche Process for the preparation of 2,3,4,5-tetrahydro - 5 - aryl - 1h - 1,4 - benzodiazepine derivatives
DK78692D0 (da) 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
IT1271026B (it) 1994-10-21 1997-05-26 Isagro Ricerca Srl Derivati dell'acido b-amminopropionico ad attivita' fungicida
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US20040152741A1 (en) 2002-09-09 2004-08-05 Nps Allelix Corporation Arylglycine derivatives and their use as glycine transport inhibitors
AU2003263155A1 (en) 2002-09-20 2004-04-08 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
AU2003215549A1 (en) 2003-02-03 2004-08-30 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
US7244852B2 (en) * 2003-02-27 2007-07-17 Abbott Laboratories Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
JP2007510662A (ja) * 2003-11-04 2007-04-26 エリクシアー ファーマシューティカルズ, インコーポレイテッド 治療化合物およびその使用
PT1904477E (pt) * 2005-07-14 2009-03-12 Hoffmann La Roche Derivados de indol-3-carbonil-espiro-piperidina como antagonistas do receptor de v1a
US8193208B2 (en) * 2005-09-09 2012-06-05 Purdue Pharma L.P. Fused and spirocycle compounds and the use thereof
EP2104677B1 (en) * 2007-01-12 2011-12-07 F. Hoffmann-La Roche AG Spiropiperidine glycinamide derivatives

Also Published As

Publication number Publication date
AU2008204491A1 (en) 2008-07-17
ATE536356T1 (de) 2011-12-15
AR064831A1 (es) 2009-04-29
US20080194610A1 (en) 2008-08-14
EP2104677B1 (en) 2011-12-07
CN101583615A (zh) 2009-11-18
TW200836728A (en) 2008-09-16
CA2674958A1 (en) 2008-07-17
CN101583615B (zh) 2012-07-04
PE20081851A1 (es) 2009-01-09
EP2104677A1 (en) 2009-09-30
US20080171759A1 (en) 2008-07-17
JP2010515700A (ja) 2010-05-13
US20080171760A1 (en) 2008-07-17
ES2376378T3 (es) 2012-03-13
CL2008000059A1 (es) 2008-07-18
AU2008204491B2 (en) 2012-05-03
KR20090097217A (ko) 2009-09-15
WO2008084005A1 (en) 2008-07-17
US7498339B2 (en) 2009-03-03
KR101129791B1 (ko) 2012-03-23
IL199583A0 (en) 2010-03-28
MX2009007411A (es) 2009-07-17

Similar Documents

Publication Publication Date Title
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
DK2209786T3 (da) Pyrimidinsubstituerede purinderivater
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0812518A2 (pt) Derivados de indazolamida
EP2226315A4 (en) 2-aminoquinazoline DERIVATIVE
BRPI0806538A2 (pt) Derivados de glicinamida de espiropiperidina
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
ATE483711T1 (de) Spiroindolinonderivate
BRPI0813836A2 (pt) Derivados pirazólicos
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
EP2233838A4 (en) COOKER
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
DK2152370T3 (da) Aryletherpyridazinonderivater
BRPI0821258A2 (pt) Derivados de ciclopropilamina
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2277 DE 26/08/2014.